Filing Details
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ:CLOV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Files Quarterly Report for Q0
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ:CLOV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ:CLOV) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Clover Health Investments filed its quarterly report (Form 10-Q) with the SEC on August 7, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.76 with a market capitalization of $1.4 billion as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual report.
Market Context
CLOVER HEALTH INVESTMENTS, CORP. /DE's stock currently trades at $4.76 with a market capitalization of $1.4B.
The 10-Q provides CLOVER HEALTH INVESTMENTS, CORP. /DE's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CLOVER HEALTH INVESTMENTS, CORP. /DE are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CLOV Stock Page
Frequently Asked Questions
Where can I read CLOV's SEC filings?
Browse all filings on our CLOV SEC filings page.
What types of SEC filings does CLOVER HEALTH INVESTMENTS, CORP. /DE file?
Public companies like CLOVER HEALTH INVESTMENTS, CORP. /DE file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.